Austin pharm.co.Ltd. announced that i will issue 2,372,368 common shares at an issue price gross proceeds of KRW 9,963,945,600 on December 26, 2022. The transaction will include participation from BioSmart Co.,Ltd. The transaction has been approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4,985 KRW | +10.65% | -6.47% | +45.55% |
1st Jan change | Capi. | |
---|---|---|
+45.55% | 79.79M | |
+21.55% | 72.37B | |
+48.33% | 65.86B | |
-4.21% | 34.41B | |
-16.43% | 28.52B | |
-7.17% | 14.26B | |
-13.03% | 9.92B | |
+5.83% | 9.52B | |
+71.16% | 8.54B | |
+26.49% | 8.36B |
- Stock Market
- Equities
- A038460 Stock
- News BioSmart Co.,Ltd.
- Austin pharm.co.Ltd. announced that it expects to receive KRW 9.9639456 billion in funding from BioSmart Co.,Ltd.